Citadel Advisors’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Buy |
|
|||||
|
2025
Q1 | $44.1K | Sell |
|
|||||
|
2024
Q4 | $178K | Buy |
|
|||||
|
2024
Q3 | $109K | Sell |
|
|||||
|
2024
Q2 | $406K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $47.4K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $21.7K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $80K | Buy |
|
|||||
|
2022
Q1 | $94K | Buy |
|
|||||
|
2021
Q4 | – | Hold |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $165K | Sell |
|
|||||
|
2021
Q1 | $296K | Sell |
|
|||||
|
2020
Q4 | $633K | Buy |
|
|||||
|
2020
Q3 | $238K | Buy |
|